Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

1,830.00p
   
  • Change Today:
    -70.00p
  • 52 Week High: 3,750.00
  • 52 Week Low: 1,800.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 5,360
  • Market Cap: £95.61m

Latest Deals

Traded Action Notifier PriceAmountValue
25-Nov-25 Buy Bruce Hiscock 2,071.00p 150 £3,106.50

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
25-Nov-25 Buy Bruce Hiscock 2,071.00p 150 £3,106.50

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 304,042 £5,563,969
Ian James Nicholson 13,500 £247,050
Bruce Hiscock 1,474 £26,974

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £95,519,705
Castlefield Fund Partners Limited 985,000 £18,025,500
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £16,195,500
Gresham House Asset Management Limited 627,782 £11,488,411
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £11,336,850
Miton Group plc 508,135 £9,298,870
The Diverse Income Trust plc 302,300 £5,532,090
Schroders plc 284,795 £5,211,748
Wasatch Advisors, Inc. 265,000 £4,849,500
Raymond James Wealth Management Limited 263,770 £4,826,991
Premier Miton Group plc 262,812 £4,809,460
Canaccord Genuity Group Inc 259,940 £4,756,902
Adrian Williams 253,372 £4,636,708

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 1,830.00p
Change Today -70.00p
% Change -3.68 %
52 Week High 3,750.00
52 Week Low 1,800.00
Volume 5,360
Shares Issued 5.22m
Market Cap £95.61m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 06-Nov-25 10-Apr-25
Paid 21-Nov-25 25-Apr-25
Amount 80.00p 70.00p

Trades for 05-Dec-2025

Time Volume / Share Price
16:27 650 @ 1,830.00p
16:37 150 @ 1,830.00p
16:37 150 @ 1,830.00p
16:35 300 @ 1,830.00p
16:35 300 @ 1,830.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page